Concourse Financial Group Securities’s Clarus Therapeutics Holdings, Inc. Common Stock CRXT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Hold
0
11257
2022
Q2
Hold
0
11030
2022
Q1
Hold
0
10781
2021
Q4
Hold
0
10315
2021
Q3
Hold
0
9568
2021
Q2
Hold
0
9006
2021
Q1
Hold
0
8359